Rep. Courtney and Rep. Houchin Introduce the Hidden Fee Disclosure Act of 2025
This bill is currently in the House Committee on Education and Workforce. It has been stalled since March 2025, and nothing has happened with the proposal for 15 months. The committee must review the bill before it can move forward, but most bills do not receive a vote at this stage.
This bill has support from both parties and addresses high healthcare costs. However, large insurance companies and drug benefit managers often lobby against these types of rules.
This bill’s path across every version that has carried it.
Reintroduced
Reintroduced from H.R. 4508 (118th), which died when its Congress ended.
H.R. 4508 (118th) →Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Department of Labor employees would need to develop new rulemaking and enforce the expanded disclosure requirements. The bill explicitly requires the Secretary of Labor to issue rules within one year. However, this is standard agency implementation work, and the broader federal workforce is not meaningfully targeted by the bill.
Referred to the House Committee on Education and Workforce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.

The legislation would insert significant transparency into the pharmaceutical supply chain by clarifying that PBMs and TPAs are required to disclose all direct and indirect compensation they receive as part of servicing a group health plan.
The Hidden Fee Disclosure Act (H.R. 4508) would attempt to address PBM transparency and loopholes identified in the No Surprises Act. It would prohibit PBMs and insurers from working with drug manufacturers if they cannot hold up their transparency requirements.
No votes or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Hidden Fee Disclosure Act of 2025
Analysis generated by AI. Always verify with official sources.